Vietnam News

Vietnam receives 500,000 Sinopharm COVID-19 vaccine doses donation from China

Vietnam has received a shipment of 500,000 Sinopharm vaccine doses donated by China, the health ministry said on Sunday, as the country is ramping up inoculations to battle against a more widespread outbreak.

The Southeast Asian nation approved China’s Sinopharm vaccine for emergency use against COVID-19 in early June. 

The vaccines will be used for three groups: Chinese citizens in Vietnam, Vietnamese who have plan to work or study in China and people who live near the borders with China, the health ministry said in a statement.

Vietnam’s domestic inoculation programme, which started in March, has so far relied heavily on around 4 million shots of AstraZeneca’s (AZN.L) vaccine.

Nearly 2.4 million people in Vietnam have had one dose of a COVID-19 vaccine, while 115,315 have been fully vaccinated, according to official data.

The country of 98 million also received a batch of nearly one million AstraZenca doses of vaccine donated by the Japanese government on June 16. 

Vietnam is tackling a more stubborn wave of infections. The country’s business hub, Ho Chi Minh City on Sunday banned public gatherings of more than three people and imposed lockdown orders on some virus-prone areas.

Vietnam’s latest outbreak, which includes the highly transmissible Delta coronavirus variant, has accounted for about 75% of its overall cases during the pandemic, with 9,849 infections and 31 fatalities since late April.

By Phuong Nguyen – Reuters – June 20, 2021

En poursuivant la visite de ce site, vous acceptez l’utilisation de traceurs (cookies) vous permettant juste d'optimiser techniquement votre navigation. Plus d’informations

En poursuivant la visite de ce site, vous acceptez l’utilisation de traceurs (cookies) vous permettant d'optimiser techniquement votre navigation. Aucune information sur votre utilisation de ce site ne sera partagée auprès de quelconques médias sociaux, de sociétés commerciales ou d'agences de publicité et d'analyse. Cliquer sur le bouton "Accepter", équivaut à votre consentement.

Fermer